Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain
Emilio Monte-Boquet; Ángeles Florez; Guillermo José Alcaín Martínez; Agustí Sellas;
Reumatol Clin. 2023;19:446-54
Update of the position paper of the Spanish Society of Rheumatology on biosimilar drugs
Miguel Ángel Abad Hernández; José Luis Andreu; Alejandro Balsa Criado; Federico Díaz-González; José Vicente Moreno Muelas; Rubén Queiro Silva; Juan J. Gómez-Reino;
Reumatol Clin. 2021;17:160-9
Effectiveness, safety and economic analysis of Benepali in clinical practice
Marta Rojas-Giménez; Natalia Mena-Vázquez; Carmen María Romero-Barco; Sara Manrique-Arija; Inmaculada Ureña-Garnica; Gisela Diaz-Cordovés; Francisco Gabriel Jiménez-Núñez; Antonio Fernández-Nebro;
Reumatol Clin. 2021;17:588-94